← Back to stories
AI

Weight-loss drugs show signs of slowing biological aging, say drugmakers

Popular weight-loss drugs may do more than help people shed pounds. They might also melt away the years.

Drug giants Eli Lilly and Novo Nordisk say patients taking their drugs age less quickly, according to readouts from molecular “aging clocks.”

Such clocks assess a person’s biological age by looking at changes to DNA that accumulate with time, or, in newer versions, by tracking levels of key proteins.

Both companies found that overweight or diabetic patients taking the drugs, called GLP-1s, had reduced biological age compared to those taking a placebo, although the difference varied widely, depending on which type of clock was used, and what organ was tested.

Overall, the difference was around “two to three years,” according to Nikolaj Roed, a global project leader at Novo, who says the company has been seeing “improved biological age in our patients across trials and across different tissues.”

The findings add to wide speculation among scientists that GLP-1 drugs, as they are …

You're reading a preview. The full article is published by MIT Technology Review on their website.

Read the full story on MIT Technology Review